As a Data Scientist at Mount Sinai Health System, you operate at the critical intersection of clinical medicine, advanced research, and operational hospital workflows. Your role is fundamentally different from a standard tech-industry data science position; you are not just optimizing algorithms for click-through rates, but rather developing models that directly impact patient outcomes, clinical trial design, and hospital efficiency. Whether you are embedded within the Clinical Data Science team or collaborating with academic departments, your work directly influences how clinicians deliver care.
The impact of this role is both immediate and profound. You will utilize electronic health records (EHR), clinical trial datasets, and operational metrics to build predictive models, design statistical frameworks, and uncover patterns in complex healthcare data. The projects you drive help doctors make informed decisions at the bedside, streamline emergency department throughput, and advance medical research. This unique blend of academic research and hospital operations makes the position highly rewarding for data scientists who want their code and analyses to have a tangible, life-saving impact.
Success in this position requires a rare combination of technical rigor and exceptional communication skills. You will work with highly specialized professionals, including senior biostatisticians, clinical directors, medical professors, and hospital administrators. Because many of your stakeholders do not have a background in statistics or machine learning, your ability to translate complex model outputs into actionable clinical insights is just as important as your ability to write clean, efficient code.
Initial HR Screening
reportedWhoever runs this call is usually not a practitioner. They take notes, and a hiring manager skims those notes later, so the real question is whether your work survives being written down by someone outside the field. Test every project sentence against that: could a non-specialist repeat it correctly without knowing what a propensity score is? Carry a plain-language version of each project and one reason you want this particular role that you could not copy onto another application. Vagueness at this stage reads as inexperience, even when the underlying work was genuinely deep.
What to demonstrate
- Whether a non-specialist can restate your projects accurately, since their paraphrase is what reaches the hiring manager
- Whether your reason for wanting the role points at the work itself rather than the company's reputation
- Whether your language signals the level being screened for: what you decided yourself versus what you were handed
How to prepare
- Write a two-sentence, jargon-free version of each major project: the question nobody could answer, and the decision your work changed. Read it to someone outside data and have them repeat it back
- Point your 'why this role' answer at something concrete in the job description or the product surface you would be working on, and keep it to two sentences
- Have two questions ready about measurement: which metric the team is held to, and who acts on an analysis once it lands
Hiring Manager Conversation
reportedExpect a live problem with pieces of it missing, closer to a conversation than an exam. A metric moved, or somebody wants to know whether a change worked, and you are asked how you would find out. The manager is watching the first ninety seconds, specifically whether you establish what decision hangs on the answer before you start proposing methods. Candidates who open with a technique get steered back. Once the decision is clear, describe what the data would look like if the story were true, and say what you would accept as evidence that it is not.
What to demonstrate
- Whether you fix the decision the analysis serves before choosing an approach
- How you continue when you are told the data you just asked for does not exist
- Whether you state what would change your mind, not only what would confirm the hypothesis you started with
- How you size an effect before you have measured it
How to prepare
- Take a metric you know well and practise explaining in under two minutes the four things that could have moved it and how you would separate them
- Pick a recent launch or experiment and write the single number you would ask for first, plus what you would conclude if it came back flat
- Practise being interrupted: have someone remove a data source halfway through your answer and carry on without restarting
Technical Evaluation
reportedMuch of what gets scored here happens out loud while you type. Nobody can see your reasoning inside a half-written query, so five silent minutes read as being stuck even when they are not. State the plan in plain language first: which tables, what grain you are aggregating to, and the one filter that defines the population. Then write it. The narration doubles as insurance, because a wrong plan gets caught early and cheaply while a wrong query gets caught at the end with no time left to redo it. A timed statistics section, where one exists, is a separate test with its own clock.
What to demonstrate
- Whether the query you write matches the plan you just described
- What you do with a hint, meaning whether the correction gets absorbed or the first approach gets defended
- Whether you can debug your own wrong output by reading the result set and naming which part of the query produced the anomaly
How to prepare
- Solve three problems while screen-sharing into a recording, then watch it back and mark every stretch longer than thirty seconds where you said nothing
- Practise compressing the plan into one sentence before typing, then check afterwards whether the finished query actually matched it
- Time yourself on statistics questions that carry a business reading, such as what a confidence interval does and does not claim, rather than re-reading notes without a clock
Collaborator Fit Interviews
reportedRounds outside the standard loop often open with something deliberately under-specified: a loose business problem, an open question about a product area, a dataset described in one sentence. The common failure is surveying, listing six plausible approaches and committing to none of them. The thing that separates a strong answer is scoping out loud. State what you are treating as the goal, name the metric you would move, say what you are choosing not to do and why, then take one path through to an actual answer. An interviewer can follow you down a narrow path. Nobody can grade a menu.
What to demonstrate
- Whether you turn an ambiguous prompt into a stated question with a measurable outcome before doing any work
- The judgement visible in what you cut, and whether you say why you cut it rather than silently dropping it
- Whether you land on a concrete recommendation with its caveat attached, rather than an unranked set of options
How to prepare
- Take three vague prompts, such as 'is this feature working', 'why did retention drop', and 'should we expand into a new segment'. For each, write one sentence of goal, one primary metric with its window, and two things you are explicitly not doing.
- Practise giving the recommendation first and the reasoning second, in five minutes. Loosely defined rounds are usually time-boxed, and an answer that arrives last often does not arrive.
- Keep a running assumption list as you talk, on paper or in the shared doc, so the interviewer can challenge one assumption instead of your whole answer.
PracHub editorial advice for the preparation topics above.
Pre-post evaluation on a high-cost or high-risk cohort
Cohorts selected on an extreme value of the outcome regress toward the mean on their own. Members identified as the top 1 percent of spend in one year spend far less the next, whether or not anyone intervenes, because the selecting year captured both chronic severity and one-off events. A pre-post design on such a cohort will report savings every time. A concurrent comparison group selected by the same rule in the same period, or a regression discontinuity at the selection threshold, is the minimum credible design.
Reading the most recent months of a claims-based series as real
Claims incur before they are reported and paid, so recent incurred months are systematically undercounted until runout completes. The lag is not uniform: pharmacy adjudicates in days, professional claims in weeks, inpatient facility claims in months. That means recent data is both too low and mix-shifted toward cheap services, which reads as a cost improvement and a utilisation drop at once. The fix is to hold the last three incurred months back or apply completion factors, and to state the paid-through date on every chart.
Reading a dozen metrics with no multiplicity control
Nominate one primary metric before launch and treat the rest as guardrails or exploratory, with Bonferroni or Benjamini-Hochberg applied when you intend to make claims from them. Twenty independent tests at 0.05 under the null produce at least one false positive about 64 percent of the time.
Extrapolating a first-week lift inflated by novelty effects
Plot the treatment effect by days since first exposure instead of quoting one pooled average. A lift that decays toward zero across the test window is behaviour that will not persist, and annualising it produces a forecast that misses by an order of magnitude.
Choose a category, try a prompt, then open its approach, worked solution or follow-up when you need it.
How do you perform an ANOVA test, and under what clinical scenarios wo…
How do you perform an ANOVA test, and under what clinical scenarios would you use it over a t-test?
Approach
- Sanity-check the answer against a simple bound or a simulated case.
- Quantify uncertainty explicitly rather than reporting a point estimate alone.
- Translate the result into the decision it informs, in one plain sentence.
Follow-up
- How would you explain this result to someone who does not know statistics?
- What sample size would you need to detect an effect half this size?
Explain the difference between correlation and causation, and how you …
Explain the difference between correlation and causation, and how you establish correlation in highly noisy clinical datasets.
Approach
- Write down the assumption the method needs before you use the method.
- Translate the result into the decision it informs, in one plain sentence.
- Quantify uncertainty explicitly rather than reporting a point estimate alone.
Follow-up
- How would you explain this result to someone who does not know statistics?
- Which assumption here is most likely to be violated in practice?
Walk me through the mathematical differences between various machine l…
Walk me through the mathematical differences between various machine learning algorithms, such as random forests and gradient boosted trees.
Approach
- Set a baseline first, so any model has something honest to beat.
- Check what information would not exist at prediction time, and exclude it.
- Pick an evaluation metric that matches the cost of each error type, not a default.
Follow-up
- What would you monitor after launch to know the model is still valid?
- Where could label leakage enter this setup?
How do you explain a complex machine learning model, such as a neural …
How do you explain a complex machine learning model, such as a neural network, to a non-statistician clinical director?
Approach
- Set a baseline first, so any model has something honest to beat.
- Pick an evaluation metric that matches the cost of each error type, not a default.
- Frame the prediction: the label, the moment of prediction, and the action it triggers.
Follow-up
- Where could label leakage enter this setup?
- How would you choose the decision threshold, and who owns that choice?
Build a claims lag triangle and complete recent months
medical_claim_line has claim_id, claim_version, frequency_code, service_start_date, paid_date, allowed_amount, claim_status. Using 24 fully mature incurred months, build a development triangle of allowed dollars by incurred month and payment lag in whole months, derive cumulative completion factors by chain ladder, then estimate ultimate allowed for the three most recent incurred months at a stated paid-through date. Deduplicate to surviving claim versions before building the triangle. Return incurred_month, paid_to_date, completion_factor, estimated_ultimate.
Approach
- Deduplicate to surviving claim versions and keep paid lines first. A triangle built on all versions develops on adjustment churn rather than on payment timing, and replacements arrive late, so the distortion concentrates in exactly the tail you are trying to estimate.
- Compute lag as a whole-month difference between incurred month and paid month, not as day difference divided by 30. Ragged month lengths otherwise shuffle identical claims between lag buckets depending on which month they fall in.
- Pivot to incurred_month by lag, cumulate along lag, then form age-to-age factors as the ratio of the column L+1 total to the column L total, summed over incurred months mature enough to have both. Volume weighting is the chain ladder; a simple mean of per-month ratios lets one low-volume month dominate the factor.
- Chain the age-to-age factors from each lag to ultimate and invert: completion factor at lag L is the reciprocal of the product of factors from L onward. Apply as estimated_ultimate = paid_to_date / completion_factor.
- State the assumption you have just made, which is that the development pattern is stable. It is not, after a claims-system migration, a network change or a processing backlog, and the most recent month's factor is the least reliable because it rests on the fewest observations while carrying the largest adjustment.
Worked solution 35 min
- Deduplicate to surviving versions, drop voids, keep claim_status 'paid', and derive incurred_month from service_start_date and paid_month from paid_date.
- lag = (paid_month.year - incurred_month.year) x 12 + (paid_month.month - incurred_month.month); drop negative lags and investigate them separately.
- Pivot to a triangle of summed allowed_amount, cumulate along the lag axis, and mask cells past the paid-through date so no cell contains a future payment.
- Compute volume-weighted age-to-age factors per lag over the mature rows, then chain them into cumulative completion factors.
- Apply the factor for each recent month's current maturity to its paid_to_date and return the four columns.
Follow-up
- A processing backlog means the last two months developed slower than history. What does your estimate do, and how would you detect that before reporting?
- Pharmacy, professional and inpatient facility develop on different clocks. How do you split the triangle, and what breaks if the service mix shifts?
- What happens to a PMPM series if someone reports an unadjusted recent month, and in which direction does the error point?
Why do you want to join Mount Sinai Health System specifically, and ho…
Why do you want to join Mount Sinai Health System specifically, and how do you see your skills contributing to our clinical mission?
Approach
- Compute rates by summing numerator and denominator separately, never by averaging rates.
- Handle the rows that do not match: a LEFT JOIN with a NULL check is usually the question.
- State the window function and its partition and ordering out loud before writing it.
Follow-up
- What breaks if events arrive late or out of order?
- How does the query change if the join becomes one-to-many?
Report site activation to first randomization without hiding non-enrollers
study_site holds one row per (study_id, site_id): site_activation_date, which is NULL for a site selected but never activated, and site_status. study_subject_visit holds subject_visit_id, study_id, site_id, subject_id, randomization_ts (NULL for screen failures), visit_name, visit_number, actual_visit_date and visit_status, with one row per subject per protocol visit, so randomization_ts repeats across every visit of a randomized subject and a site that has screened nobody has no rows there at all. For one study_id and a stated data cut date, return per activated site the activation date, the first randomization_ts and the days between them, with activated sites that have randomized nobody still present. Add a study-level summary giving median days to first randomization and the share of activated sites with no randomization by day 90.
Approach
- Take the site universe from study_site, never from study_subject_visit. The visit table can only contain sites that have screened at least one subject, so a universe built from DISTINCT site_id there omits exactly the sites this metric exists to expose. Filter study_site to the study and to site_activation_date IS NOT NULL, then LEFT JOIN the per-site first randomization.
- Collapse the grain before aggregating anything on the visit side. The table repeats randomization_ts across every visit of a randomized subject, so any count taken at row grain is inflated by visits per subject. MIN(randomization_ts) per site is safe, COUNT is not.
- State the date boundary rule. randomization_ts is a timestamp and site_activation_date is a date, so a randomization at 23:40 local time can land on either side of a day boundary depending on the zone the timestamp is stored in. Cast once, deliberately, and say which zone.
- Use PERCENTILE_CONT(0.5) WITHIN GROUP (ORDER BY days) for the median and be explicit that it ignores NULLs, so it is a median over enrolling sites only. That is exactly why the non-enroller share is reported beside it rather than instead of it.
- Censor the day-90 denominator against the data cut. A site activated 40 days before the cut has not had 90 days to randomize, so it cannot be scored on that bar and belongs outside that denominator.
Worked solution 25 min
- CTE sites: site_id and site_activation_date from study_site for the study where site_activation_date IS NOT NULL. The (study_id, site_id) key already gives one activation date per site, so assert that key rather than de-duplicating defensively.
- CTE first_rand: site_id and MIN(randomization_ts) over study_subject_visit rows for the study where randomization_ts IS NOT NULL, grouped by site_id.
- LEFT JOIN sites to first_rand and compute days_to_first_randomization with an explicit cast of the timestamp to a date.
- Summary: PERCENTILE_CONT(0.5) over non-null days, plus the count and share of sites with no randomization by day 90, restricted to sites activated at least 90 days before the data cut.
- Compare the site-level row count with COUNT(DISTINCT site_id) in study_subject_visit for the study; the difference is the activated sites that have screened nobody, which is the population the metric is for.
Follow-up
- The same site_id appears under two studies. What breaks, and what is the correct grain for this metric?
- Would you present this as a median, as a Kaplan-Meier curve of time to first randomization, or both, and what does the curve show that the median cannot?
- A site randomized one subject who withdrew at visit 2. Does that site count as enrolling here, and how does that differ from a randomized-and-retained measure?
How do you assess statistical significance in a study with a small coh…
How do you assess statistical significance in a study with a small cohort size?
Approach
- Name the randomisation unit first; it decides the variance and what the test can detect.
- Name the guardrails that would stop a launch even on a positive primary result.
- State the primary metric and the minimum effect worth shipping, then size the test.
Follow-up
- How would you handle interference between treated and control units?
- What would you conclude if the result is positive but the test is underpowered?
Describe your process for data cleaning when dealing with inconsistent…
Describe your process for data cleaning when dealing with inconsistent electronic health record (EHR) entries.
Approach
- State your assumptions explicitly before working the problem.
- Work from the decision backwards to the evidence you would need.
- Say what you would check first and why it is the highest-information step.
Follow-up
- How would you know your answer was wrong?
- What assumption would you test first?
Estimate a programme effect at a fixed risk-score enrolment cutoff
Care management enrols members whose prospective_risk_score in member_enrollment crosses a fixed annual threshold of 1.75; above the line enrolment is near-automatic and below it unavailable, and about 85 percent of members above the line actually enrol. Leadership refused a randomised holdout and wants the programme's effect on next-year allowed PMPM. Two years of scores and claims are available. State the design, the estimand it identifies, the assumptions, and the diagnostics you would run before reporting anything.
Approach
- Propose a fuzzy regression discontinuity on prospective_risk_score at 1.75. Uptake jumps but is not complete, so the estimator is the ratio of the jump in outcome to the jump in enrolment probability at the cutoff, which is a Wald ratio.
- State the estimand honestly up front: a local effect for members near 1.75, who are the least sick enrollees. It does not identify the effect on the top risk decile, which is usually the number leadership actually wants, and saying so before the result lands is what keeps the analysis credible.
- Say explicitly why the obvious alternative fails. A pre-post on enrolled members selects on a high score in year one, and such cohorts regress toward the mean in year two whether or not anything is done, so a pre-post design reports savings every time. The discontinuity is immune because it compares members on either side of an arbitrary line.
- Specify the estimation: local linear fits on each side, triangular kernel, a data-driven MSE-optimal bandwidth, and robust bias-corrected inference rather than a naive local-linear confidence interval. Do not fit a high-order global polynomial.
- Run the falsification suite before looking at the effect: a density test for manipulation of the running variable, continuity of pre-determined covariates at the cutoff, sensitivity across bandwidths, and placebo cutoffs away from 1.75.
Worked solution 30 min
- Plot the outcome and the enrolment rate against the centred running variable in uniform bins to confirm a visible jump in both.
- Estimate the first stage (jump in enrolment probability at 1.75) and the reduced form (jump in next-year PMPM), then take the ratio for the fuzzy RD estimate.
- Select the bandwidth by an MSE-optimal rule with a triangular kernel and local linear fits, and report robust bias-corrected intervals.
- Run the density test at 1.75 and the covariate continuity tests on age, prior-year cost, dual_eligible_flag, and product_type.
- Re-estimate at 0.5x, 1x, and 2x the selected bandwidth, and at placebo cutoffs of 1.50 and 2.00.
Follow-up
- Risk scores are built from coded diagnoses, and coding intensity is something people can influence. What would manipulation look like in the density, and what do you do if you see it?
- The MSE-optimal bandwidth leaves 900 members. How do you decide whether to report an underpowered estimate at all?
- Design an encouragement version instead: randomise the invitation rather than enrolment. What does instrumental variables buy you, and which assumption is most at risk?
Readmission rate rose while every facility improved
Quarter over quarter the 30-day unplanned readmission rate for an attributed population rose from 14.2 to 15.1 percent, yet all eleven facilities in encounter show a flat or falling rate over the same period. You have encounter (facility_id, admit_ts, discharge_ts, encounter_type, admission_type, discharge_disposition, drg_code, is_planned_admission, index_encounter_id) and twelve months of prior medical_claim_line for comorbidities. Explain the direction reversal numerically, and state what the population-level number should be reported as instead.
Approach
- Confirm the reversal is arithmetic, not a definition difference, by recomputing both the facility rates and the pooled rate from the same query with the same index-stay exclusions.
- Decompose the pooled change exactly with a Kitagawa split. With facility weights w and within-facility rates r, the change equals the sum over facilities of (w_1 - w_0) times (r_0 + r_1)/2, the mix term, plus the sum of (w_0 + w_1)/2 times (r_1 - r_0), the within term. If the mix term exceeds the total change and the within term is negative, the reversal is volume shifting toward facilities with higher baseline rates.
- Ask why the weights moved. Check index-stay volume by facility, and check whether an exclusion changed behaviour: acute-to-acute transfers (discharge_disposition 'transfer_acute') must not open an index stay, and if one facility began transferring more, its denominator shrinks toward its sickest retained patients.
- Check case mix inside the facilities too, using drg_code and comorbidities drawn from the 12 months of claims before admit_ts, excluding complications of the index stay itself. A facility rate can be flat while its case mix worsens.
- Replace the raw pooled rate with an observed over expected ratio, where expected is the sum of predicted probabilities from a model fitted on age, sex and prior comorbidities. Raw rates are not comparable across a population whose facility and case mix is moving.
Follow-up
- Your O/E ratio is 1.04 with a 95 percent interval of 0.96 to 1.13. What does that let you say to a facility, and what does it not?
- If one facility contributes 40 percent of index stays, how does that change how you present the decomposition?
- How would you handle a member with two index stays in the quarter, where the second is also a readmission from the first?
For a candidate whose interviews will centre on A/B testing, metric movement and causal claims. Design comes before arithmetic, arithmetic before analysis, and the week ends by rehearsing the readout rather than the derivation.
Prepare, practise & reflect
One practical outcome each day. Spend longer where you need it.
0 / 7 done01Design one test end to end on paper
- Take a single feature change and write the full design: randomization unit, the exact point of exposure, the primary metric with its grain, guardrails, allocation, planned duration, and the decision rule committed before any data exists.
- Write why the randomization unit must sit at or above the level where treatment can spill over, and give one case where user-level randomization is still contaminated (shared accounts or devices, or two participants in the same marketplace).
- State in advance what you will do if the primary metric is flat while a secondary metric is significant.
Deliverable: A one-page test design with a decision rule written before launch.
Practice prompt ↗Practice prompt ↗Worked solution ↗02Power arithmetic until it is automatic
- Compute required sample size per arm for a binary metric with the normal approximation, n is approximately 2 times (z for alpha/2 plus z for power) squared times p(1 minus p) divided by delta squared, for baselines of 2, 10 and 40 percent at a 5 percent relative lift, and note that for a fixed relative lift the requirement falls as the baseline rises because delta grows proportionally with p.
- Redo the calculation for a continuous metric using variance in place of p(1 minus p), and show why a heavy-tailed quantity such as revenue per user needs either far more traffic or a capped version with a stated cap.
- Convert one of the results into weeks given a weekly eligible traffic figure, then list the two honest ways to shorten it (accept a larger detectable effect, or reduce variance) and write why quietly lowering the power target is a decision to miss more real wins, not a speedup.
Deliverable: A small script or sheet that maps baseline, minimum detectable effect, alpha and power to sample size and weeks, cross-checked against a published calculator.
Practice prompt ↗Practice prompt ↗03Variance and the unit-of-analysis problem
- Take a ratio metric whose denominator is not the randomization unit (clicks per session, randomized by user) and compute the standard error twice, once naively at session level and once by the delta method or a user-level bootstrap, then record how much the naive version understates it.
- Implement CUPED on simulated data: choose a pre-period covariate X measured before assignment, estimate theta as Cov(Y, X) divided by Var(X), and analyse Y minus theta times (X minus its mean) in place of Y. Confirm the variance of the adjusted outcome equals the raw variance multiplied by one minus the squared correlation between Y and X, so a correlation of 0.45 removes about 20 percent of the variance and not 80.
- Now run that simulation a few hundred times and confirm the adjusted effect estimate is unbiased for the same effect rather than numerically identical to the raw one. Within any single run the two differ, sometimes by a large fraction of the true effect, because the two arms' pre-period covariate means never coincide exactly in a finite sample; they agree in expectation, which is the property that matters and the one to state out loud.
Deliverable: A notebook showing the adjusted estimator with a measurably smaller variance than the raw one, plus a repeated-simulation table showing the two estimators agreeing on average while differing run by run.
Practice prompt ↗Practice prompt ↗04Validity threats you can actually test for
- Run a sample ratio mismatch check as a chi-square goodness-of-fit test against the intended allocation, and write the three causes you would chase first (assignment logged before exposure, an arm-specific redirect or load failure, bot filtering applied asymmetrically).
- Simulate peeking: generate A/A data, test daily at alpha 0.05 across 14 looks, record the inflated false positive rate, then apply an alpha-spending boundary or commit to a fixed horizon and confirm the rate returns to nominal.
- Write how you would separate a novelty effect from a durable lift using the treatment effect plotted against days since first exposure, and what shape would change your recommendation.
Deliverable: One table showing the peeking false positive rate before and after correction, plus a written SRM triage list.
Practice prompt ↗Practice prompt ↗Worked solution ↗05When randomization is not available
- Write the identifying assumption for difference-in-differences (parallel trends in the absence of treatment), then plot pre-period trends for two candidate control groups and justify rejecting one of them.
- Design a switchback test for a change where user-level randomization would leak across participants, choosing a time-block length against the carryover you expect and saying how you would detect carryover in the data.
- List what an interrupted time series or a synthetic control buys you and the one thing neither can rule out: an unobserved shock that coincides with the launch.
Deliverable: A one-page memo recommending a single quasi-experimental design and naming its weakest assumption explicitly.
Practice prompt ↗Practice prompt ↗06The readout query
- Write the assignment-to-exposure join that returns exactly one row per unit per experiment, and handle units appearing in both arms by excluding and counting them rather than silently keeping one.
- Compute the per-arm metric, its variance and the relative lift with a confidence interval in SQL, then reproduce the identical numbers in a notebook as a cross-check.
- Add a segment breakdown and write the sentence that keeps it from being p-hacking: segments declared in advance, everything else reported as exploratory and corrected for multiplicity.
Deliverable: A single query that outputs the full readout table, matched to a notebook recomputation.
Practice prompt ↗Practice prompt ↗07Present it to someone who will not read the appendix
- Give a 10-minute readout of a real or simulated experiment in the order decision, number, uncertainty, caveat.
- Have your listener ask "can we ship it" in the case where the primary is flat and a guardrail moved, and answer with a recommendation rather than a request for more data.
- Rewrite your opening line so the recommendation lands before any methodology.
Deliverable: A one-page readout whose first line is the recommendation.
Practice prompt ↗Practice prompt ↗Worked solution ↗Expand any day for tasks and deliverables. Your progress is saved on this device.
Half of this section is about translation. Be ready to describe how you explained a result to someone who did not want the method, only the implication, and what you did when the simplified version started being repeated in a way that overstated it. Correcting your own simplification is a strong beat.
Describe a time when a research project did not go as planned. How did…
Describe a time when a research project did not go as planned. How did you pivot your approach?
Approach
- Quantify the outcome, including what you would not claim credit for.
- Name the disagreement or constraint, and how you resolved it with evidence.
- Pick a story where you drove the decision, not one where you observed it.
Follow-up
- What would you do differently if you ran that project again?
- What did you decide not to do, and why?
How do you handle highly imbalanced datasets, such as when predicting …
How do you handle highly imbalanced datasets, such as when predicting a rare clinical event or disease?
Approach
- Quantify the outcome, including what you would not claim credit for.
- Close with what you would do differently, concretely.
- Pick a story where you drove the decision, not one where you observed it.
Follow-up
- What would you do differently if you ran that project again?
- What did you decide not to do, and why?
Defend a null result against a programme sponsor
A care management programme enrolled the top 1 percent of members by prior-year allowed spend. The sponsor's deck shows allowed PMPM for enrollees falling 34 percent from the year before enrollment to the year after, and asks for budget to triple the programme. You rebuild the evaluation with a concurrent comparison group selected by the identical spend rule in the same period. The difference-in-differences estimate is a 3 percent reduction with a confidence interval spanning zero. Deliverable: how you present this, to whom, in what order, and what you propose next.
Approach
- Name the probe: whether you can deliver a finding that costs somebody their programme without softening it into uselessness or creating an adversary who routes around you next time.
- Lead with the mechanism, not the verdict. Show the comparison group's own unadjusted drop, which will be large, because a cohort selected on an extreme of the outcome regresses toward the mean whether or not anyone intervenes. The sponsor's 34 percent is mostly that, and it is a property of the selection rule rather than a criticism of their clinicians.
- Give the sponsor the finding privately before it appears in any deck their leadership sees. Being surprised in a room is what turns a methods disagreement into a political one.
- State the estimate with its interval and say what it rules out as well as what it fails to establish. A 3 percent point estimate whose interval crosses zero is not evidence of no effect; it is insufficient power to separate a modest effect from none, and those are different claims.
- Arrive with a design rather than only an objection. Propose a regression discontinuity at the enrollment threshold if the rule is applied sharply, or a randomised rollout across the next wave of eligible members, and state the sample size needed to detect the effect size the sponsor believes in.
Follow-up
- The sponsor says withholding the programme from a comparison group is unethical. What do you propose instead?
- Leadership wants one number for the board next week. What do you give them?
- What result would change your mind and make you believe the 34 percent?
- 01
Describe a time when a research project did not go as planned. How did you pivot your approach?
- 02
How do you handle highly imbalanced datasets, such as when predicting a rare clinical event or disease?
- 03
A care management programme enrolled the top 1 percent of members by prior-year allowed spend. The sponsor's deck shows allowed PMPM for enrollees falling 34 percent from the year before enrollment to the year after, and asks for budget to triple the programme. You rebuild the evaluation with a concurrent comparison group selected by the identical spend rule in the same period. The difference-in-differences estimate is a 3 percent reduction with a confidence interval spanning zero. Deliverable: how you present this, to whom, in what order, and what you propose next.
Is this an official Mount Sinai Health System interview guide?
No. It is PracHub's own research and practice material for the Data Scientist role at Mount Sinai Health System. Rounds and questions reflect what candidates have reported, not a process Mount Sinai Health System has published, and they change over time. Confirm the current format and scope with your recruiter.
PracHub interview research ↗How technical is the interview process for a Data Scientist at Mount Sinai?
The technical rounds are rigorous but focus heavily on core fundamentals rather than complex, abstract coding challenges. You should expect to be thoroughly tested on statistics (such as ANOVA and correlation), basic machine learning algorithms, and data preprocessing techniques (like handling NaN values). The interviewers value a deep, intuitive understanding of these concepts over memorizing niche algorithms.
PracHub interview research ↗What is the work culture like on the Clinical Data Science team?
Candidates consistently describe the team culture as passionate, collaborative, and highly mission-driven. Under leadership like Director Arash, the team is deeply committed to bridging the gap between academic research and hospital operations. It is an environment where your work has a direct, visible impact on patient care and hospital workflows.
PracHub interview research ↗How important is communication for this role?
Communication is a critical evaluation criterion. Because the nature of the job involves collaborating with many non-statisticians, including doctors, nurses, and administrators, you must be a strong communicator who can translate complex data insights into actionable clinical strategies.
PracHub interview research ↗What is the typical timeline for the interview process?
The process is relatively straightforward and typically lasts several weeks. It often begins with an HR screen, followed by a conversation with a hiring manager or professor, and concludes with a series of technical and collaborative interviews, which are sometimes scheduled back-to-back on the same day.
PracHub interview research ↗Sources & methodology 3 sources ↗
No official company page is cited. Rounds and questions come from candidate reports and PracHub editorial material; each source shows the date it was read.
- 01PracHub interview research ↗
PracHub editorial research into this company and role, maintained with this guide. Candidate-reported, not an employer publication.
PracHub page · Accessed 2026-09-22 - 02PracHub Data Scientist practice ↗
Cross-company practice questions for this role.
PracHub page · Accessed 2026-09-22 - 03PracHub interview preparation framework ↗
The framework the preparation plan follows.
PracHub page · Accessed 2026-09-22
Explore related engineering environments and compare the preparation focus.
Veracyte Data Scientist Interview Questions & Guide 2026
Causal-inference exercises for Veracyte data scientist prep: difference-in-differences, matching, instrumental variables, and knowing when observational data simply cannot answer the question asked.
Zoetis Data Scientist Interview Questions & Guide 2026
Metric-diagnosis practice for Zoetis data scientist candidates: a number moves week over week and you work out why, splitting by segment, ruling out a logging or release change, and separating a mix shift from a real change in user behaviou
Vizient Data Scientist Interview Questions & Guide 2026
Communication practice for Vizient data scientist candidates: turn an analysis into a recommendation, name the uncertainty honestly, and answer the follow-up a skeptical stakeholder will raise.
Vibrant Emotional Health Data Scientist Interview Questions & Guide 2026
Case practice for the Vibrant Emotional Health data scientist interview, where the prompt is deliberately underspecified and your first move is scoping it into something measurable.